BIONEERCORPORATION

064550 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ
₩9,970.00
+7.44%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Moderate debt: debt-to-equity of 0.63.
  • Current assets comfortably cover current liabilities (current ratio 2.25).
  • Sales have compounded about 44% a year over five years.

!Watch-points

  • Return on equity is on the lower side at -1.3%.
  • Return on capital employed is on the lower side at 5%.
  • Net profit margin is slim at 0.5%.
  • Profit growth has been slow over five years (about -51% a year).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
1.09

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreModerate
4 / 5

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 5 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₩2,573억
Current Price₩ 9,970.00
High / Low₩ 15,640.00 / 5,470.00
Stock P/E-91.47
Book Value₩ 8,124.03
ROCE5.01%
ROE-1.34%
Debt to Equity0.63
Current Ratio2.25
EPS₩ -109.00
PAT Margin0.52%
ICR2.64
Compounded Sales Growth
10 Years
5 Years 44.48%
3 Years
TTM
Compounded Profit Growth
10 Years
5 Years -50.83%
3 Years
TTM
Stock Price CAGR
10 Years
5 Years
3 Years
1 Year
Return on Equity
10 Years
5 Years
3 Years
Last Year -1.34%
Educational data only. Not a recommendation to buy, sell or hold any security.